Project Number 1R01AG033693-01A1 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for EFFECTS OF SIMVASTATIN ON CSF AD BIOMARKERS IN COGNITIVELY NORMAL SUBJECTS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator LI, GAIL Principal Investigator First Name GAIL Principal Investigator Last Name LI Awardee Organization UNIVERSITY OF WASHINGTON Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-062: Alzheimers Disease Pilot Clinical Trials (R01) FY Overall Cost $481,629 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
